CovidVax show full list
COVID-19 VACCINE:

VaxiPatch microneedle array dermal patch

researcher:
Verndari + University of California Davis
https://www.verndariinc.com/
https://www.ucdavis.edu/
(USA)
vaccine type: Protein subunit
Distribution updates
currently no distribution info
Human Testing updates (clinical trials)
May 17Verndari's CEO hopes to be able to start clinical trials on humans this summer (by verndariinc.com)
Animal Testing updates (pre-clinical trials)
start date: April 2020
Apr 29Verndari will begin preclinical testing this week of a potential vaccine using its patented VaxiPatch (by verndariinc.com)
early development updates
currently no early development info



funding:
$ 680.000 from BARDA
Aug 26Verndari announced funding from BARDA to support development of Verndari's VaxiPatch technology (by businesswire.com)



contact | about | ©2020 CovidVax.org project